Dual Mobility Cups in Hip Fracture Patients

Femoral Neck Fractures Clinical Trial

— DUALITY  

Official title:

Do Dual Mobility Cups Prevent Dislocation After Total Hip Arthroplasty Performed Due to Femoral Neck Fracture? A Registry-based, Pragmatic, Randomized Controlled Trial Comparing Dual Mobility With Standard Cups

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03909815
• Other study ID #: 2018-101
• Status: Recruiting
• Phase: N/A
• Start date: January 17, 2020
• Est. completion date: December 31, 2024

Study information

• Verified date: November 2023
• Source: Uppsala University
• Contact: Nils Hailer, MD
• Phone: +46186119038
• Email: nils.hailer[@]surgsci.uu.se
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Our aim is to develop a strategy that reduces the risk of dislocations after total hip arthroplasty surgery performed due to femoral neck fracture. We therefore perform a register-nested, pragmatic, randomized controlled trial to investigate the safety and efficacy of dual mobility cups that were designed to minimize the risk of dislocation in the large and fragile group of elderly patients with femoral neck fractures.

Description:

Total hip arthroplasty (THA) is regularly performed in patients with a femoral neck fracture. However, dislocation is very common after THA in hip fracture patients, and this complication is deleterious to health and quality of life. The dual mobility cup offers a technical solution that potentially reduces the risk of dislocation. There is however no high-level evidence to support the general use of dual mobility cups in patients with displaced femoral neck fractures, and the purpose of the proposed study is to provide evidence to support or refute the use of this concept in the very large group of hip fracture patients. We a register-nested, pragmatic randomized controlled trial (RCT) to investigate the safety and efficacy of dual mobility cups that were designed to minimize the risk of dislocation after THA. Our aim is thus to investigate whether the incidence of dislocations after THA surgery performed due to femoral neck fracture can be reduced by the use of this device. The intervention group receives a dual mobility cup (of any brand that is in general use in Sweden), and the control group receives a standard cup (of any brand that is in general use in Sweden). The choice of cup or stem fixation (cemented or uncemented), femoral head size, brand of stem type, surgical approach, antibiotic prophylaxis, and postoperative mobilization are up to the surgeon's choice and the routines that are relevant at each study site. The necessary infrastructure for this register-nested RCT is present within the Swedish Hip Arthroplasty Register (SHAR) and the Swedish Fracture Register (SFR). Pre-operative registration of fractures is already established within the SFR, and an online platform to screen, include and randomize eligible patients is established. Cross-matching of data from the SFR and the SHAR with the database of the Swedish Patient Register (SPR) is performed in order to catch endpoint not routinely collected by the SHAR. Expanded recruitment in collaboration with UK, WHITE 12-Duality, started 10/09/2022. https://www.isrctn.com/ISRCTN11895196

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1600
• Est. completion date: December 31, 2024
• Est. primary completion date: June 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Written informed consent
• Diagnosis: displaced femoral neck fracture type AO 31-B2 or B3/Garden type 3 or 4
• Eligible for THA according to local guidelines and routines

Exclusion Criteria:

• Previous inclusion of contralateral hip
• Delayed fracture surgery (date of injury >7 days prior to date of randomization)
• Pathological or stress fracture of the femoral neck, or fracture adjacent to a previous ipsilateral hip implant
• Inability or unwillingness to give written consent
• Dementia (as diagnosed by the screening physician)
• Unavailability of both interventions for a study subject (e.g., implants being out of stock, or lack of the individual surgeon's expertise to perform either procedure)

Related Conditions & MeSH terms

• Femoral Neck Fractures
• Fractures, Bone

Intervention

Device:
• Dual mobility cup
Patients with a displaced femoral neck fracture eligible for THA receive a dual mobility cup, as opposed to a standard cup in the control group.
• Standard cup
Patients with a displaced femoral neck fracture eligible for THA receive a standard cup, as opposed to a dual mobility cup in the experimental group.

Locations

Country	Name	City	State
Sweden	Nils Hailer	Uppsala

Sponsors (2)

Lead Sponsor	Collaborator
Uppsala University	The Swedish Research Council

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dislocation	Dislocation will be ascertained by identifying the occurrence of any closed or open reduction of the previously inserted THA (the "index joint") within one year after surgery.	1 year after index surgery
Secondary	Any re-operation of the index THA	Re-operation will be defined as the occurrence of any surgical procedure performed on the previously treated hip within one year after surgery.	1 year after index surgery
Secondary	Periprosthetic joint infection	Periprosthetic joint infection will be defined as the occurrence of any sign of deep infection around the previously inserted THA within one year after surgery, defined by registration of ICD or NOMESCO codes.	1 year after index surgery
Secondary	Patient-reported outcome	Patient-reported outcome as assessed by EQ-5D-VAS (routinely collected by the SFR at index surgery in order to obtain pre-trauma baseline, and 1 year post-operatively)	1 year after index surgery
Secondary	Short-term mortality	90-day mortality, as registered in the NPR	90 days after index surgery
Secondary	Medium-term mortality	365-day mortality, as registered in the NPR	365 days after index surgery
Secondary	Cost-effectiveness	Procedural costs for intervention and control treatment will be recorded at all sites, ensuring documentation of baseline costs for the two treatment alternatives. Procedural costs of admissions for closed reductions as well as for reoperations will also be collected from all units.	1 year after index surgery